Insight into the Genetics and Genomics Studies of the Fritillaria Species

The plant genus Fritillaria has been used for thousands of years as a source of various pharmaceutically active compounds. Research into the genome, molecular phylogeny, and pharmacology of Fritillaria species has led to the discovery of a wide variety of bioactive molecules, including steroidal alkaloids, saponins, terpenoids, glycosides, and others. DNA markers have shown to be an effective scientific tool for determining the population structure and variety of Fritillaria, making them a viable conservation tool. Despite natural selection's common association with plant growth and ecology, very little is known on the subject of genome size and the selective pressures that shape it. Selection on the fundamental drivers of genome growth, such as transposable elements and gene duplication, may impact the many cellular and physiological implications of huge genome size of Fritillaria species. Therapeutic plants have been bred with the use of conventional biotechnology methods. It is time to hasten the use of biotech-based breeding techniques for these crucial plants. Genetics and biotechnology have the potential to expedite the genetic enhancement of medicinal plants via analyses of genetic diversity, conservation efforts, propagation, and over-production of specialized metabolites of commercial usage. This chapter presents a thorough overview of research conducted on the genetics and genomics of Fritillaria species, establishing the basis for the plant's conservation and sustainable commercial exploitation for industrial purposes.